Pancreatic Cancer Research

ResearcherUniversity of California, San FranciscoActive in the last 2 years

Frank Patrick Mccormick

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-6619-7120; OpenAlex author ID A5082685256, A5113680132; NIH RePORTER profile ID 2446782. Sources: funder_awards.

Their work

Papers
4 (first author 0, last author 1)
Trials
0
Grants
3
Labs led
1
Collaborators
8
Papers, trials and grants by year

2010: 1 grant · 2011: none · 2012: none · 2013: none · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: 1 paper · 2020: none · 2021: 1 paper · 2022: 1 paper, 1 grant · 2023: 1 paper · 2024: none · 2025: 1 grant

Papers 4

  1. Oncogenic KRAS promotes pancreatic ductal adenocarcinoma (PDAC) through post-transcriptionally regulated KRAS-induced granules (KGs) Co-author DOI 10.21203/rs.3.rs-3064215/v1↗
  2. Novel Regulators of Macropinocytosis-Dependent Growth Revealed by Informer Set Library Screening in Pancreatic Cancer Cells. Co-author DOI 10.3390/metabo12090831↗
  3. UDP-glucose pyrophosphorylase 2, a regulator of glycogen synthesis and glycosylation, is critical for pancreatic cancer growth. Co-author DOI 10.1073/pnas.2103592118↗
  4. Blockade of leukemia inhibitory factor as a therapeutic approach to KRAS driven pancreatic cancer. Last author DOI 10.1038/s41467-019-11044-9↗

Grants 3

  1. Stephenson Global Prize: Frank McCormick AWARD stephenson:2025-frank-mccormick-phd-stephenson-global-prize-frank-mccormick
  2. New Ways of Targeting K-Ras R35CA197709↗
  3. Specific K-Ras Inhibitors for Treating Pancreatic Cancer AWARD pancan:2010-frank-mccormick-phd-specific-k-ras-inhibitors-for-treating-p

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Sung Eun Kim · 3 shared papers, 2019–2022 · strength 0.40
  2. Angelina S. Bortoletto · 1 shared paper, 2023 · strength 0.22
  3. Ronald J. Parchem · 1 shared paper, 2023 · strength 0.22
  4. Sang Hoon Kim · 1 shared paper, 2022 · strength 0.16
  5. Andrew L. Wolfe · 1 shared paper, 2021 · strength 0.12
  6. Man‐Tzu Wang · 1 shared paper, 2019 · strength 0.11
  7. Jeremy M. Sharib · 1 shared paper, 2019 · strength 0.11
  8. Eric Andrew Collisson · 1 shared paper, 2019 · strength 0.11

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.